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Abstract 
 
There is growing appreciation that a developmental perspective is helpful in Psychiatry. 
However, clinical practice and research, especially in an era of very large sample sizes, 
often ignore the developmental context. In this perspective piece, we discuss why a 
developmental view is important in Psychiatry and how recent genetic-epidemiological 
findings further highlight this.  
 
DSM-5 childhood neurodevelopmental disorders such as ADHD, typically onset in early 
childhood but can persist into adult life; the same ADHD genetic loading appears to 
contribute across the life-course. However, recent longitudinal studies have observed that 
ADHD symptoms may emerge later during adolescence and adult life in some individuals 
although the etiology of this late-onset group is unclear.  
 
The epidemiology and genetics of depression do not appear to be the same in childhood, 
adolescence and adult life. Recent genetic findings further highlight this. Autistic type 
problems and irritability also appear to show developmental variation in their genetic 
etiology. These findings raise the question of whether social communication and irritability 
have the same meaning at different ages. Schizophrenia typically onsets after adolescence. 
However, it is commonly preceded by childhood antecedents that do not resemble 
schizophrenia itself but do appear to index schizophrenia genetic liability.  
  
We conclude that there is a need for clinicians and scientists to adopt a developmental 
perspective in clinical practice and research– by considering age-at-onset and changes over 
time as well as different developmental periods when interpreting clinical symptoms.  
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Introduction 
It is well recognized that physical, behavioral, brain and biological phenotypes are subject to 
changes across the life-span and that such transformation is especially marked during fetal 
life, childhood and adolescence. Many of these changes are normative and arise as a result 
of typical developmental processes (e.g. an increase in height during childhood); others 
represent departures from a typical developmental trajectory (e.g. a shift from the 50th to 5th 
centile on a childhood height centile chart). There is growing appreciation from biological, 
imaging, genetic and clinical studies that a developmental perspective is important for 
investigating psychiatric disorders. However, clinical practice and sometimes research, 
especially in an era when very large sample sizes need to be amassed, often ignore the 
developmental context. That is because investigating developmental processes and taking a 
life-course perspective typically require longitudinal investigations that are time-consuming 
and expensive (see Figure 1a). 
 
The argument that developmental approaches are useful to Psychiatry is not new; this has 
been argued strongly by Rutter for decades.1 In this perspective piece, we revisit why a 
developmental view is important in Psychiatry using recent findings from genetic-
epidemiology studies – particularly those using polygenic risk scores (PRS). This article is 
not intended to be a comprehensive review; rather we have deliberately selected papers, 
many of which are our own, to illustrate key points for this perspective piece. However we 
emphasize that a broad range of psychiatric and applied neuroscience research that include 
investigations of environmental exposures, epidemiological, genetic, transcriptomic and 
imaging studies 1-4 also illustrate the importance of a developmental perspective but are 
beyond the scope of this article.  
 
Timing of onset for different psychiatric disorders 
Around 75% of psychiatric disorders onset by childhood, adolescence or early adult life (mid 
20s).5 Thus, it can be argued that investigation into risk and protective exposures, risk 
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mechanisms as well as prevention and early intervention programs need to start very early 
in life. Also, the peak age of incidence for many psychiatric disorders, such as depression, 
coincides with the transition from “childhood/adolescence” to “adult” life. The sharp divide 
between child/adolescent and adult psychiatry research and clinical services is unhelpful 
here and can be a barrier to adopting a developmental approach. 
Although there is growing recognition that different neuropsychiatric disorders show strong 
phenotypic6 and genetic7, 8 overlap with each other, they are also distinctive in many 
respects. An obvious difference is that they display varying times of onset or at least 
manifest at different times9, 10 (see Figure 1b) although what explains this variation is 
unknown at present. One possibility is that the timing of exposure to a risk factor (e.g. 
prenatal life vs. adolescence) matters. Also, risk factors vary across the life-course. For 
example, hormonal changes associated with puberty are likely to have greatest impact in 
adolescence, a time period when the incidence of depression rises. Other stressors also 
change across development - such as family or school stressors in childhood, employment-
related stress in adulthood and chronic illness in the elderly. 
 
Neurodevelopmental disorders as grouped by DSM-511 include autism, ADHD, learning, 
communication and motor disorders and intellectual disability and are defined as having an 
onset in the early developmental period, typically in early childhood.12 They tend to have a 
steady rather than remitting and relapsing course10, 11 and their core features show marked 
maturational changes from childhood to adult life. It is now recognized that these disorders, 
or at least some symptoms and impairment, persist well into adult life for many.  
 
It has been long recognized that Conduct Disorder shows distinctive developmental courses. 
Childhood-onset persistent conduct problems begin early and are strongly associated with 
neurocognitive deficits, ADHD, a higher genetic loading and poorer prognosis.13 In some 
regards, this group appear to share many similarities with neurodevelopmental disorders: 
early-onset, many but not all show a chronic life-course trajectory, prominent neurocognitive 
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deficits and a male excess. Another group show an emergence of conduct problem after 
puberty. Individuals in this group do not show an elevated rate of ADHD or cognitive deficits, 
tend to improve in adult life and the social /peer context is thought to contribute risk in this 
group.14 A developmental approach enabled these different groups to be identified yet 
clinical research of adolescent conduct disorder would group them as a single entity. 
Childhood-onset (<10 years) and adolescent-onset behavioral problems however are 
distinguished as subtypes in DSM-5. 
 
The typical timing for the onset of anxiety disorders depends to a large extent on the type of 
anxiety problem.15, 16 For example, separation anxiety and specific phobias typically onset in 
childhood; social anxiety disorder more commonly arises in childhood and adolescence and 
agoraphobia, panic disorder and generalized anxiety disorder most commonly manifest in 
later adolescence or early adulthood. Symptoms of some anxiety disorders are 
developmentally normative at a young age (e.g. separation anxiety in toddlers). As for 
neurodevelopmental disorders, symptoms of anxiety disorder need to be assessed with a 
developmental view but there is no clear-cut guidance on how best to do this.16 
 
Mood disorders and schizophrenia typically rise in incidence from late-adolescence onwards 
and are rare in prepubertal children. However, longitudinal, population-based studies as well 
as investigation of high-risk offspring of parents with depression, bipolar disorder or 
schizophrenia have shown that these disorders are commonly preceded by earlier mental 
health problems such as anxiety, irritability or mild hypomania.17, 18 We will focus on 
schizophrenia where a developmental perspective has been informative. 
 
Childhood antecedents of schizophrenia  
While the core defining features of schizophrenia typically first onset in late adolescence or 
adult life (e.g. hallucinations, delusions), it can be preceded by earlier neurocognitive and 
developmental impairments including language, social, motor and attentional difficulties in 
6 
 
early childhood.10 These so-called childhood antecedents also have been observed in the 
high-risk offspring of parents with schizophrenia. It has been unclear however whether these 
early impairments create risk for later schizophrenia or represent an early manifestation of 
underlying liability. A recent study examined schizophrenia polygenic genetic risk scores 
(PRS), a composite measure of the total burden of risk alleles derived from a large 
patient/control schizophrenia discovery genome-wide association study (GWAS), in a 
prospective population-based cohort.19  Schizophrenia PRS were found to be associated 
with language, social communication, cognitive and behavioral traits as young as age 4 
years. In adolescence, schizophrenia PRS also have been found to be associated with 
anxiety in the general population.20 These findings suggest that the antecedents observed in 
high-risk studies may be the early manifestations of underlying schizophrenia genetic 
liability, or alternatively these could be causal risk factors.  
 
Studies of pre-pubertal children carrying highly penetrant rare mutations such as 22q11 
microdeletion syndrome also show that even though around 1 in 4 carriers are likely to 
develop schizophrenia, as children, these individuals show a broad range of 
psychopathology including ADHD, autism spectrum disorder, anxiety as well as cognitive 
impairments.21 Findings from these studies converge with those from recent gene 
expression studies. These implicate enrichment of schizophrenia associated genes identified 
from GWAS with brain expression profiles manifest during the prenatal period.22 These 
findings all suggest that the core defining features of schizophrenia are a late manifestation 
of an underlying disorder process that starts well before adolescence and adult life. 
 
Depression: same disorder at different ages? 
DSM-5 no longer isolates childhood depression and anxiety diagnostic criteria but rather 
takes a lifespan approach to classification. There are strong arguments for viewing 
depression and anxiety as lifespan disorders because child and adolescent forms of disorder 
appear to show strong links with the same later disorders in adult life. Also, both disorders 
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are familial; the children of parents with anxiety or depression are at elevated risk for these 
same disorders. These findings suggest that for anxiety and depression, the same 
underlying liability operates across childhood, adolescence and adult life. 
However, there are some complications to viewing depression and anxiety as a single 
developmental continuum. First, epidemiological studies consistently show marked 
differences in the gender ratio for pre-pubertal depression in childhood and depression in 
adolescence and adult life. In childhood, males and females are equally affected, whilst after 
mid-adolescence, females are much more commonly affected.23, 24  
 
Second, while post-pubertal onset major depressive disorder shows strong continuities with 
depression in adult life, pre-pubertal-onset depression does not appear to show this 
continuity but rather shows links with later antisocial behavior.10, 25 Third, treatment 
responses are not identical in children, adolescents and adults. Tricylic antidepressants 
while not first line treatment for depression in adults have been found to be an effective 
treatment; however one meta-analysis in children, found them to be ineffective in this age 
group. Even serotonin reuptake inhibitors generally have been found to be less effective in 
young people such that in some countries only fluoxetine is licensed for those under the age 
of 18 years,26 and they have been reported to be more commonly associated with suicidal 
thoughts in younger people27 so careful monitoring is required. These findings suggest that 
depression/anxiety are not necessarily the same at different ages. If this is the case, it could 
have important clinical and research implications. 
 
Finally, turning to etiology, early family and twin studies highlighted that major depressive 
disorder28 and depression symptoms29 also show etiological heterogeneity indexed by age-
of-onset or age. More recent molecular genetic studies also are beginning to suggest age-at-
onset and age differences in the genetic architecture of depression and we will consider 
findings from these (see Table 1). The largest GWAS study of depression in patients to 
date30 (predominantly adults) found that an early age-of-onset (before 27 years: S 
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Hagenaars and C Lewis, written communication, June 21st 2018) was associated with 
schizophrenia PRS whereas “later-onset” depression was associated with depression PRS 
in keeping with a previous study.31  
 
Findings from the longitudinal population-based UK 1958 birth cohort, also observed that 
schizophrenia PRS were found to be associated with a measure of emotional problems 
(anxiety/depression) across childhood, adolescence, early-adult life and  mid-adulthood 
whereas depression PRS associations were more consistently associated with emotional 
problems in mid-adulthood.32 While stronger associations with schizophrenia compared to 
depression PRS could reflect that the former is a stronger instrument, this does not explain 
differential findings for depression PRS by age. 
 
A more recent longitudinal UK population-based cohort study focused on an earlier 
developmental period and investigated depression symptom trajectories from childhood to 
late adolescence.33 This study identified a group whose depression symptoms emerged in 
early-adolescence and another group whose symptoms emerged later in adolescence. Both 
depression groups were associated with depression PRS but interestingly the early 
emerging depression group additionally was associated with schizophrenia and ADHD PRS. 
This early-onset depression group also showed elevated levels of childhood ADHD and 
other neurodevelopmental traits. 
 
Taking together these three studies, we speculate about the possibility that there is a very 
early-onset form of depression that is characterized by a more prominent 
neurodevelopmental component. It remains to be seen whether this very early-onset group, 
like those observed in earlier clinical and epidemiological studies fails to show continuity with 
typical forms of depression in adult life. 
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The most recent molecular genetic study of youth depression was based on the Danish 
iPsych cohort that utilized health record registry data and included those with a clinic 
recorded diagnosis of depression from age 10 years onwards.34 These investigators also 
observed somewhat higher schizophrenia PRS in earlier-onset depression (those aged 10 to 
15 years) with MDD PRS showing strongest associations for depression with age at onset 
between 16 to 25 years. They additionally observed that earlier-onset depression was 
associated with bipolar PRS. This cohort has the advantage of being focused on patients 
and being very large but of course clinically referred depression is not the same as 
population-based depression. The authors did not report results for ADHD PRS. It is 
unknown to what extent these observations reflect pleiotropy (schizophrenia and bipolar 
PRS increasing risk for depression as well as for schizophrenia and bipolar disorder) or 
whether some early-onset cases are misclassified as depression and over time will manifest 
as bipolar disorder or schizophrenia. Regardless, the findings are consistent with multiple 
other studies in that they vary for depression at different ages.  
 
There are now decades of epidemiological, twin and now molecular genetic studies as well 
as pharmacological studies highlighting that a developmental perspective to investigating 
depression and anxiety will be important for better understanding it and certainly in an era 
where stratification, precision medicine and personalized medicine are priorities. That is a 
big challenge, especially for genomic discovery studies where very large sample sizes are 
required, individual data and developmental data are typically unavailable. 
 
ADHD: what happens over time 
For DSM-5 defined neurodevelopmental disorders including ADHD, the core symptoms and 
impairments of neurodevelopmental disorders can show maturational improvements 
although for many individuals, deficits remain in adult life.10, 11 For example, ADHD 
hyperactive-impulsiveness symptom levels decline with age; this age-related decline in 
inattention problems is less prominent. In acknowledgement of this developmental change, 
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DSM-5 has now reduced the number of ADHD symptoms required in adolescence and 
adulthood for a diagnosis of ADHD However, there is little known about typical trajectories of 
ADHD and other neurodevelopmental disorders in adult life and guidance on how to adjust 
diagnostic assessments according to the developmental context in either clinical practice or 
research. This is important given longitudinal studies of ADHD,35 autism,36 language,37 
reading38 and spelling problems39 show that a substantial proportion of affected individuals 
continue to meet full diagnostic criteria in adult life or at least display some symptoms and 
manifest impairment in adult life. These findings are a reminder that many individuals with 
childhood neurodevelopmental disorders do not grow out of them as was a common belief 
previously nor do they represent a maturational lag40 whereby affected children eventually 
“catch up”. However, alterations in the developmental context (for example, not being 
required to sit school exams) may mean that the nature and level of difficulty and impairment 
changes. Nevertheless, there is substantial variability in individual developmental trajectories 
and the reasons behind this are largely unknown yet may provide some clues for optimizing 
outcomes. Here we take the example of ADHD.  
 
Family and twin studies all suggest that stronger familial and genetic loading for ADHD are 
associated with ADHD continuity into adolescence and adult life.41-43 A recent, longitudinal, 
population-based study examined repeated measures of ADHD symptom scores from ages 
4 to 17 years and association with ADHD PRS.44 Overall ADHD symptom scores declined 
for the majority; but two groups differentiated those with a persistently high level of ADHD 
symptoms (through to adolescence) and those whose symptoms declined or remitted by 
adolescence (childhood-limited). ADHD PRS distinguished the high persistent group from 
the childhood-limited group (and from the other groups). Interestingly although there is such 
strong genetic overlap between different neuropsychiatric disorders, schizophrenia, bipolar 
and major depression PRS were not associated with the ADHD developmental trajectories. 
PRS are unavailable in clinics and in any case are only weakly predictive. However, an index 
of neurodevelopmental and behavioral multi-morbidity - lower IQ, autistic problems, 
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language problems and conduct problems - also were observed to be associated with ADHD 
PRS burden and independently predicted a persistent trajectory.  These findings overall 
suggest that the genetic contribution to childhood ADHD also contribute to its persistence in 
adult life. More recently, independent genome-wide association studies of adult ADHD and 
child ADHD also showed strong genetic correlation between adult ADHD and child ADHD;45 
again suggesting that while ADHD symptoms might show developmental change, the 
genetic correlates do not appear to be very different.  
Interestingly, several recent longitudinal studies adopted a developmental life-course 
perspective to assessing ADHD and identified an apparent “late-onset” form of ADHD where 
ADHD symptoms were not reported in childhood but emerged newly in adolescence or adult 
life.46 These individuals would not meet current diagnostic criteria for ADHD if their age-at-
onset was known and the discovery of this group challenges the conceptualization of ADHD 
as a neurodevelopmental disorder. Three studies investigating “late-onset” ADHD have not 
observed associations with ADHD PRS, although these have been limited in power due to 
sample size.44, 47, 48 Thus, while childhood and persistent ADHD appear to be genetically 
similar, this may not be the case for “late-onset” ADHD. Further work is needed on this late-
onset group.  
 
Autistic symptoms in childhood and adolescence 
It has been known for a long time from family and twin studies that autism is familial, highly 
heritable and genetically associated with a broader spectrum of social and communication 
difficulties.49, 50 More recent molecular genetic studies also have highlighted that clinically 
diagnosed autism shows genetic overlap with broadly defined social communication traits in 
the general population.51 Autism, like other child neurodevelopmental disorders is not 
restricted to childhood and many affected individuals continue with persistent problems into 
adult life. However emerging findings from one recent longitudinal cohort study suggest that 
social communication traits not only show change in their phenotypic manifestation over time 
but also in their genetic architecture.52 
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This UK population-based cohort used psychiatric GWAS findings to examine the latent 
genetic architecture of social communication traits from ages 8 to 17 years. The authors 
found that while there was some genetic stability across ages, most of the genetic 
contribution at age 17 years came from a novel genetic factor at age 11 years, highlighting 
novel adolescent processes.52 The same research group also found that while autism PRS 
showed association with social communication traits in the general population in childhood, 
this association declined with age.53  
 
Interestingly, social communication problems were also found to be associated with 
schizophrenia PRS; however, this association was strongest in late adolescence. The 
findings raise the possibility that the meaning of social communication problems may be 
different across ages but further work on this is needed. 
 
Can a developmental perspective help classify or subtype psychopathology? The 
example of irritability 
In this next section we consider the clinical phenomenon of irritability: specifically, whether it 
is best conceptualized as a mood, behavioral or ADHD-like neurodevelopmental problem. 
This knowledge could help shape clinical management in the future. Severe irritability, 
commonly defined as increased anger relative to peers, is a common reason for referral to 
clinical services and is a growing management problem to clinicians.54 It is trans-diagnostic55 
and has been a topic of some controversy because of uncertainty as to how it should be 
conceptualized in childhood. Irritability is a feature of the behavioral problem, oppositional 
defiant disorder (ODD) and factor analyses have shown that ODD separates into distinctive 
irritable, headstrong and hurtful dimensions.56 The most recent ICD-11 includes irritability as 
a specifier of ODD. However, in DSM-5, chronic, severe childhood-onset irritability is 
classified as Disruptive Mood Dysregulation Disorder (DMDD) and under Mood Disorders. 
The rationale for this comes from epidemiological studies that have observed prospective 
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association between irritability and later depression and a twin study that showed high 
genetic overlap between irritability and depression.57 
 
However, irritability and a closely related construct, emotional lability, are also strongly 
associated with ADHD. Indeed, irritability was once considered a core feature of early 
conceptualizations of ADHD.58 The view that irritability is closely related to ADHD is 
strengthened by findings from a twin study that showed genetic overlap between emotional 
lability and ADHD and cohort and patient studies that have found that irritability is associated 
with ADHD PRS.59, 60 
Thus, it is difficult to resolve how best to conceptualize irritability. A developmental 
perspective could help here.  
 
In a recent longitudinal cohort study conducted by us, irritability was assessed repeatedly 
over childhood and adolescence. Irritability symptom levels were high for males in childhood 
(higher than females) but then declined in adolescence. The pattern was different for 
females in whom irritability levels increased in adolescence (higher than males).60 In further 
analyses using growth mixture modeling, the longitudinal data was used to class different 
irritability groups that differed in their ages-of-onset.61 One group was characterized by a 
childhood-onset, elevated level of irritability that was more common in males. This group 
was associated with higher levels of both ADHD and depression and also associated with 
ADHD PRS (even when those with a diagnosis of ADHD were excluded). Another group 
showed irritability onset in adolescence and a female preponderance. This group was 
associated with a diagnosis of depression and depression (as well as ADHD) PRS.  
 
These findings require replication but we hypothesize that irritability might be both ADHD- 
like (or ODD-like) and depression-like but that developmental context could be important in 
differentiating irritability types. That could have important future implications for treatment 
and classification systems. 
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Considerations for the future: challenges and potential ways forward 
The idea of a developmental perspective in Psychiatry being important is not new. However 
in this perspective article, we focused on recent genetic-epidemiological findings, particularly 
GWAS and PRS findings. While, this research has limitations, when findings are taken 
together with those from other research designs, they once again highlight the importance of 
a developmental perspective. Differential PRS associations for what appears to be the same 
phenotype, depending on age or age-at-onset, suggest possible etiological differences 
across development. Such findings may help refine phenotype definitions and inform 
potential stratification. The findings are also relevant to clinicians who will need to consider 
age-at-onset and developmental changes over time as well as different developmental 
periods when interpreting a given clinical presentation. Traditionally, there has been a 
tendency to ignore developmental issues in clinical practice and psychiatric research and 
this might in part be due to a variety of different challenges. One challenge lies in the 
measurement of psychiatric disorder. While categories can be useful for clinical decision 
making, psychiatric disorders appear to lie at the extreme of continuously distributed 
dimensions.62 Dimensional approaches including R-Doc do have many advantages. 
However, these assume that any given dimension, for example negative valence, has the 
same meaning in early childhood as early adult or mid- life for example.  
Future important questions include does the same symptom, construct, dimension mean the 
same thing at different ages? This could be tested in a variety of ways, for example by 
assessing etiology, neural correlates, future trajectories and outcomes. 
 
A second challenge is the divide between child/adolescent and adult research and services. 
For example, different measurement approaches are used in childhood/adolescence and 
adult life including different types of measure and informant (e.g. parent, teacher vs. self). 
Longitudinal studies that attempt to utilize the same sorts of measures across ages 
especially across the adolescent/adult divide could help with investigating important 
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questions about the natural history of psychopathology, continuities and discontinuities 
across time, when trajectories are altered and how these are affected by environmental 
exposures. Transition clinical services that bridge adolescence and young adult life could 
also help address the divide. 
 
Issues that require further investigation include testing whether age-at-onset helps 
distinguish clinically useful subgroups in terms of selecting treatments and predicting 
prognosis. Can we consider some mental disorders as deviant developmental trajectories 
and if so, what is the natural history of these trajectories and what modifiable factors alter 
them and when? Are there differences across different countries that could provide clues 
about causal risks and prevention or intervention targets? 
 
A third challenge lies in obtaining reliable data across the life span. Unfortunately, 
retrospective reports for dating onset of disorder and for recalling early symptoms63 and 
environmental exposures64 are unreliable. Ideally developmental studies require longitudinal 
studies that start in very early life and continue through to late-adulthood.  
 
Given growing evidence of the importance of early brain development in relation to 
psychiatric disorder, prospective pregnancy-birth cohorts are especially attractive. Such 
studies have shown enormous value because they start before the onset of disorder, focus 
across different diagnoses, typically take a dimensional as well as a categorical approach to 
measurement65 and include multiple risk factors measured across the life-course. However 
prospective cohort studies suffer from non-random attrition and are less suited to 
investigating rare exposures (e.g. very preterm birth) and less common outcomes (e.g. 
schizophrenia, bipolar disorder). However prospective high-risk studies (e.g. offspring of 
parents with mental illness; enriched for a known risk factor such as rare mutation or preterm 
birth) as well as nationwide prospective clinical registry data can be useful additions here. 
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Conclusions 
We emphasize in this article that a developmental perspective is important for all clinicians 
and researchers spanning from neuroscientists, geneticists, epidemiologists to those 
conducting treatment trials and that this approach is currently timely. It does bring challenges 
for our measurement of psychopathology, classification and research framework as well as 
research design and services but there are some solutions. We urge for a greater focus on 
developmentally orientated research, for clinicians to adopt a developmental perspective in 
clinical practice and for scientists to bring a developmental perspective to a broad range of 
science. 
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Figure 1a. A developmental view of psychiatric disorders 
 
 
Figure 1b. Typical ages-at-onset for different types of psychiatric disorders 
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Table 1. Genetic-epidemiology studies investigating depression heterogeneity based on age or age-at-onset 
 Sample  Total N Phenotype Age-based groups Early associations Later associations 
Power et al. 
2017 
PGC 
MDD 
Patient 155,907 Major depression Early onset (≤27 years) and 
adult onset (>27 years) 
Schizophrenia and 
bipolar PRS 
 
Riglin et al. 
2018 
NCDS Population 5,257 Emotional problems Childhood (7-16 years) and 
adulthood (23-42 years) 
Schizophrenia PRS Schizophrenia and 
depression PRS 
Rice et al. 
2018 
ALSPAC Population 5,416 Clinically significant 
depressive symptoms 
Early-adolescence-onset (12 
years) and later-adolescence-
onset (16 years) trajectories 
Schizophrenia and 
ADHD PRS* 
Depression PRS 
Musliner et 
al. 2019 
iPSYCH Population 34,573 Diagnosis of 
depression 
First diagnosis aged 10-15, 
16-20, 21-25 or 26-31 years 
Schizophrenia, bipolar 
and depression PRS 
Schizophrenia and 
depression PRS 
ALSPAC=Avon Longitudinal Study of Parents and Children; MDD= Major Depressive Disorder; NCDS=National Child Development Study; 
PGC= Psychiatric Genomics Consortium; PRS=polygenic risk scores. *Multivariable analyses 
 
